Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections.
Matylda ResztakPaulina ZalewskaJacek WachowiakAgnieszka Sobkowiak-SobierajskaFranciszek K GłówkaPublished in: European journal of clinical pharmacology (2024)
and CYPC19 phenotype. The combination of repeated TDM and genotyping is necessary to ensure effective treatment.